Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 75Active not recruiting 50Completed 11Not yet recruiting 6Terminated 3Withdrawn 2Enrolling by invitation 2

Sponsor Class

OTHER 66INDUSTRY 37NIH 4NETWORK 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Dermatologic 1Breast 1

Conditions

Melanoma 1Lymphatic Metastasis 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

gamma-Globulins 1encorafenib 1binimetinib 1alovudine 1Surveys and Questionnaires 1Prednisone 1Methylprednisolone Hemisuccinate 1Methylprednisolone Acetate 1Methylprednisolone 1Infliximab 1Immunoglobulins, Intravenous 1Immunoglobulins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × NETWORK × 30 days × Clear all
NCT04438382 2026-05-15

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

Eastern Cooperative Oncology Group

Phase 2 Terminated
1 enrolled 1 chart
Other hematologic neoplasm

Hematologic Neoplasms

NCT04221438 2026-05-12

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Eastern Cooperative Oncology Group

Phase 2 Terminated
3 enrolled 11 charts
Dermatologic

Lymphatic Metastasis, Melanoma

NCT05076266 2026-05-05

COVID-19 Related Financial Hardship and Distress in Women Who Decline TMIST (EA1151) Participation

Eastern Cooperative Oncology Group

Terminated
14 enrolled 10 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡